Focal Adhesion Protein Antibody Sampler Kit #13430
Product Information
Kit Usage Information
Protocols
- 3285: Western Blotting, Immunoprecipitation (Magnetic), Immunohistochemistry (Paraffin)
- 4021: Western Blotting, Immunohistochemistry (Paraffin)
- 4650: Western Blotting
- 6487: Western Blotting, Immunofluorescence*
- 7074: Western Blotting
- 11990: Western Blotting, Immunoprecipitation (Magnetic)
- 12065: Western Blotting, Immunoprecipitation (Agarose)
Product Description
The Focal Adhesion Protein Antibody Sampler Kit provides an economical means to evaluate proteins involved in focal adhesions. The kit includes enough antibody to perform two western blot experiments per primary antibody.
Specificity / Sensitivity
Each antibody in this kit recognizes endogenous total levels of its specific target protein. Paxillin (D9G12) Rabbit mAb recognizes endogenous levels of total paxillin protein and recognizes all human paxillin isoforms. Vinculin Antibody detects endogenous levels of total vinculin protein and also reacts with metavinculin, a 145 kDa splice variant of vinculin.
Source / Purification
Monoclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Phe316 of human α-actinin-1 protein, surrounding Lys193 of human paxillin protein, and near the carboxy terminus of human talin-1 protein. Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Glu710 of human FAK protein, surrounding Arg1555 of human tensin 2 protein, and residues near the amino terminus of human vinculin protein. Polyclonal antibodies are purified by Protein A and peptide affinity chromatography.
Background
Focal adhesions connect the cytoskeleton with the extracellular matrix (ECM), a complex structure of secreted macromolecules that surrounds mammalian organs and tissues. Integrins clustered on the extracellular side of focal adhesions relay signals from the ECM to intracellular protein complexes that signal the actin cytoskeleton to regulate tension for cell motility. Internal signals converge on focal adhesions to regulate integrin receptor affinity and avidity. Signaling through focal adhesions regulates cell adhesion, migration, proliferation, apoptosis, and gene expression, and impacts cellular processes such as development, wound healing, immune response, invasion, metastasis and angiogenesis (reviewed in 1-3). Focal adhesion kinase (FAK) is a widely expressed cytoplasmic protein tyrosine kinase involved in integrin-mediated signal transduction. Integrin clustering triggers FAK recruitment to the focal adhesion complex (4). Talin is a large, multidomain focal adhesion protein that interacts with the intracellular domains of integrins and other focal adhesion proteins. Talin is involved in the formation of focal adhesions and in linking focal adhesions to the actin cytoskeleton (5). Paxillin is a key component of integrin signaling that localizes primarily to focal adhesion sites in the extracellular matrix (6). Tyrosine phosphorylation of paxillin is required for integrin-mediated cytoskeletal reorganization (7). Paxillin is phosphorylated by FAK at Tyr118 (8,9). Vinculin is a cytoskeletal protein involved in regulation of focal adhesions and embryonic development (10-13). Active vinculin translocates to focal adhesions where it may be involved in anchoring F-actin to the membrane and regulating cell migration. Vinculin binds a number of proteins, including talin, α-actinin and paxillin (11,13). Tensin 2 localizes to focal adhesions of various tissues and exhibits highest expression in heart, kidney, and liver (14,15). Tensin 2 belongs to a family of cytoskeletal proteins that include Tensin 1-3 and Cten, which couple integrins to the actin cytoskeleton (16). Tensin family proteins play an important role in signal transduction, cell proliferation, and motility (17-20). α-actinin is a member of the spectrin family of cytoskeletal proteins that was first recognized as an actin cross-linking protein, but also interacts with a large number of cytoskeletal signaling proteins, including those involved in cellular adhesion, migration, and immune cell targeting (21).
- Burridge, K. et al. (1988) Annu Rev Cell Biol 4, 487-525.
- Calderwood, D.A. et al. (2000) J Biol Chem 275, 22607-10.
- ffrench-Constant, C. and Colognato, H. (2004) Trends Cell Biol 14, 678-86.
- Parsons, J.T. et al. (2000) Oncogene 19, 5606-13.
- Nayal, A. et al. (2004) Curr Opin Cell Biol 16, 94-8.
- Turner, C.E. (2000) J Cell Sci 113 Pt 23, 4139-40.
- Burridge, K. et al. (1992) J Cell Biol 119, 893-903.
- Bellis, S.L. et al. (1995) J Biol Chem 270, 17437-41.
- Bellis, S.L. et al. (1997) Biochem J 325 ( Pt 2), 375-81.
- Izard, T. et al. (2004) Nature 427, 171-5.
- Humphries, J.D. et al. (2007) J Cell Biol 179, 1043-57.
- Witt, S. et al. (2004) J Biol Chem 279, 31533-43.
- Xu, W. et al. (1998) Development 125, 327-37.
- Clark, K. et al. (2010) J Cell Biochem 109, 808-17.
- Hafizi, S. et al. (2002) Biochem Biophys Res Commun 299, 793-800.
- Lo, S.H. et al. (1994) Bioessays 16, 817-23.
- Lo, S.H. et al. (1994) J Cell Biol 125, 1067-75.
- Chen, H. and Lo, S.H. (2003) Biochem J 370, 1039-45.
- Katz, M. et al. (2007) Nat Cell Biol 9, 961-9.
- Chen, H. et al. (2002) Proc Natl Acad Sci U S A 99, 733-8.
- Otey, C.A. and Carpen, O. (2004) Cell Motil Cytoskeleton 58, 104-11.
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。
专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
U.S. Patent No. 7,429,487, foreign equivalents, and child patents deriving therefrom.
All other trademarks are the property of their respective owners. Visit our
Trademark Information page.